Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion type Assertion NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_head.
- NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion description "[Patients with RRP expressed more CCL17 (p = 0.003), CCL18 (p = 0.0003), and CCL22 (p = 0.007) in their plasma than controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_provenance.
- NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion evidence source_evidence_literature NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_provenance.
- NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion SIO_000772 23019074 NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_provenance.
- NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion wasDerivedFrom befree-2016 NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_provenance.
- NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_assertion wasGeneratedBy ECO_0000203 NP1016202.RAYkanTu1OqweK0IIG8nn3F5mxOpaNh9zf9D-PfqRY2NE130_provenance.